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Transdermal delivery of most drugs is precluded by the barrier
characteristics of the stratum corneum (SC). Chemical penetration
enhancers are capable of interacting with SC constituents, inducing
a temporary reversible increase in the skin permeability. The aim
of this work was to assess the influence of glycerol monooleate
(GMO)/solvents systems on percutaneous absorption across
hairless mouse SC of a lipophilic drug, progesterone (PG), as well
as its effect on the SC structural characteristics, by scanning
electron microscopy (SEM) and confocal laser scanning microscopy
(CLSM). The morphological changes observed in the hairless mouse
SC suggest a GMO effect on the skin barrier. In addition, the
increase in the in vitro PG flux and in vivo penetration of a
fluorescent label point towards GMO as a potential absorption
enhancer. The results obtained showed that GMO/solvents systems
provoked changes in the SC that could be causing increased
permeation of PG across hairless mouse skin, optimising in this
way the transdermal delivery of this drug.
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INTRODUCTION
The skin has attracted much attention as an
alternative route for administering systemically active
drugs. The potential advantages associated with
transdermal drug delivery are well documented (Guy et
al., 1987). However, very few drugs can be administered
transdermally due to the low permeability of the skin,
predominantly attributed to its outermost layer, the
stratum corneum (SC), a multilayered wall-like structure
in which keratin-rich corneocytes are embedded in an
intercellular lipid-rich matrix. It has been assumed that the
transport of substances across the SC occurs via both the
intra and intercellular routes, the intercellular lipids being
the most important for the percutaneous absorption of
most permeants (Abraham et al., 1995).
Chemical and physical approaches to increase
transdermal transport have been explored in efforts to
enhance skin permeability and expand the range of drugs,
which can be delivered transdermally (Chang et al., 2000;
Obata et al., 2000; Sung et al., 2000). In theory, the rate of
skin permeation of drugs can be increased either by varying
vehicle composition in order to increase the solubility of
drugs in the skin, or by altering skin permeability to the
drug. In this case, chemical penetration enhancers have
been extensively used. Ideally, an enhancer should be
chemically and pharmacologically inert, non-toxic, non-
irritant and non-allergenic. It might have a rapid and
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reversible onset of action, be potent at low concentrations
and compatible with the formulation ingredients. Various
vehicles have been identified as penetration enhancers.
Many of these substances however, have been associated
with untoward reactions such as acute and chronic
inflammation of subcutaneous tissue. To overcome this
problem, compounds that cause relatively less skin irritation
have been studied as new candidates for percutaneous
absorption enhancers, including natural components of skin
lipids which have long-chain saturated or unsaturated fatty
acids (Williams, Barry, 1992).
Glycerol monooleate (GMO) is a fusogenic and
polar lipid of interest in a number of areas ranging from
controlled uptake to release of cosmetic, food and
pharmaceutical formulations (Qiu, Caffrey, 2000). It is
capable of interacting with phospholipid bilayers and, like
other lipids, has been proposed as a penetration enhancer
(Maggio, Lucy, 1976; Ogiso et al., 1995).
In the present work, the influence of GMO on the
percutaneous absorption of progesterone (PG) through
hairless mouse skin was studied by evaluating in vitro
permeation parameters. Morphological methods, such as
scanning electron microscopy (SEM), which provide
visualization of the structure of SC, were useful to deter-
mine the influence of penetration enhancers on SC
structure (Bentley et al., 1997). Confocal laser scanning
microscopy (CLSM) was used to provide information
about the in vivo penetration of a fluorescent label
(fluorescein) across hairless mouse skin under the
influence of GMO.
 MATERIALS AND METHODS
Chemicals
Glycerol monooleate (GMO), progesterone (PG),
fluorescein and type III trypsin were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). All the other
chemicals used were of analytical grade; solvents used in
HPLC were of HPLC grade.
Preparation of hairless mouse SC samples for the pre-
treatment and in vitro permeation studies
Abdominal full-thickness skin was excised from
male, one month old, HRS/J-Jackson Laboratories, Bar
Harbor, ME hairless mice; subcutaneous fat and connective
tissue were removed using forceps. The SC was prepared by
floating abdominal full-thickness skin for 14 h on a water
solution containing 0.1% (w/v) trypsin and 0.5% (w/v)
sodium bicarbonate at room temperature. The mushy
epidermis was removed by rubbing with moistened cotton
tipped applicator. The transparent SC sheets obtained, were
briefly rinsed with distilled water, blotted dry and kept in a
desiccator until ready for use. SC sheets were examined in
optical microscope in order to verify the presence of holes.
Samples presenting holes were not used in the experiments.
Pre-treatment procedure
Hairless mouse SC sheets were hydrated by floating on
phosphate buffered saline (pH 7.2) with stirring, for 3 h at
37 oC. During this period, a formulation consisting of 20%
(w/v) GMO in mineral oil was placed over the SC. Only mi-
neral oil was also studied. After 3 h, the SC sheets were rinsed
with ethanol (50% v/v) and used for in vitro experiments. SC
sheets without pre-treatment were used as controls. For each
formulation, 10 hairless mouse SC sheets were used.
In vitro permeation studies
The in vitro permeation study was carried out at 37 °C,
using ten modified Franz-type diffusion cells assembled with
a hairless mouse SC sheet mounted between the donor and
acceptor chambers. The receptor solution was 10% (v/v)
ethanol in distilled water, changed at each sampling time to
maintain sink conditions. The donor solutions [1 mL of
saturated PG (infinite dose) in mineral oil containing 20% (w/
v) GMO] were applied on upper surface of SC non-
occlusively. Controls without GMO was also tested. Samples
from the receptor phase were withdrawn at predetermined
times and analysed by HPLC. When pre-treated hairless
mouse SC sheets were used, the donor solutions were 1 mL
of saturated solutions of PG in mineral oil.
HPLC assay
Analyses of all samples of the in vitro permeation
studies were performed according to the method proposed
by Pereira et al. (2000). A Shimadzu Instruments HPLC
System, UV detector at 254 nm, C18 reversed-phase
column 125 mm x 4 mm (5 mm), C18 pre-column 4 mm x
4 mm (5 mm) was used. A methanol:water (70:30)
mixture was used as the mobile phase, at a flow rate of
1 mL/min and an injection volume of 20 μL. The extraction
was carried using chloroform. Medroxyprogesterone was
the internal standard. The retention times were 8.0 min and
10.0 min for the internal standard and progesterone,
respectively. The detection sensitivity of this HPLC
method for progesterone was 300 ng/mL, with less than
1% intra-day variation, and less than 3% inter-day
variation.
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Scanning electron microscopy (SEM)
Freshly excised abdominal skin samples (~1 cm2,
n=6) from hairless mice were incubated for 2 h at room
temperature in 50% (v/v) ethanol aqueous solution
containing 20% (w/v) GMO. After fixation with 3% (w/v)
glutaraldehyde in 0.1 M sodium cacodylate buffer for 3 h
and post-fixation with 1% (w/v) osmium tetroxide for 2 h,
the samples were dried using increasing concentration of
ethanol, coated with gold and viewed under a Jeol JSM
Scanning Electron microscope. Approximately 10 skin
samples were studied for each formulation. Control skins
treated only with 50% (v/v) ethanol water solution were
also tested.
Confocal laser scanning microscopy (CLSM)
Formulations containing 100 μg/mL of the fluores-
cent label (fluorescein) and 20% (w/v) GMO in a 50% (v/v)
ethanol water solution were applied on the dorsal region of
the mice and left for 3 h. The controls were untreated skin
samples or skin treated with formulations without GMO.
After the treatment, the animals (n=6) were sacrificed by
cervical dislocation and treated skin areas removed. A
mechanical cross-section (perpendicular series) was made
from the skin samples. The samples were embedded in a
matrix, frozen at –17 °C and sectioned at 40 μm thickness.
To avoid interference by fluorescence from damaged cells,
the mechanical cross-section of the skin was examined by
CLSM, 10 μm below the cutting surface (De Rosa et al.,
2000). A krypton-argon laser line at 488 nm was used for
excitation; emission was detected at 530 nm. Confocal
Microscope LEICA-DMIRBE, software LEICA TSCNT
1.5.451, equipped with Kripton-Argon laser and a 16X
immersion objective was used. To investigate the
autofluorescence properties of the skin, samples were first
observed in the absence of fluorescein. The autofluo-
rescence of hairless mouse skin was found to be very low
for the confocal settings used in this study. Because fluores-
cein is not chemically similar with PG, it was used only as
fluorescent probe for visualization of GMO effect in the
skin.
Statistical analysis
Statistical comparison was made using the non-
parametric Kruskal-Wallis test and Dunn’s multiple ran-
ge test with the help of an SAS program. The level of
significance was taken as P< 0.05.
RESULTS AND DISCUSSION
In this work the potential use of GMO/solvents
systems for PG transdermal delivery, a lipophilic model
drug, was investigated. The influences of GMO in mine-
ral oil and pre-treatment on the in vitro percutaneous
absorption profiles of PG across hairless mouse SC are
shown in Figure 1. A linear relationship was obtained
when the total amount of progesterone in the receptor
phase was plotted against time. GMO/mineral oil systems
FIGURE 1 - In vitro permeation of progesterone across hairless mouse SC: (a) from ( ) 20% (w/w) GMO in mineral
oil ( ) mineral oil (control); (b) following the pre-treatment with ( ) 20% (w/w) GMO in mineral oil ( ) mineral oil
(control). SC: stratum corneum; GMO: glycerol monooleate.
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increased the PG flux with or without the pre-treatment
with these systems (Table 1). The linear relationship
observed in the Figure 1 suggests that the percutaneous
transport of PG from GMO in mineral oil across hairless
mouse SC followed zero order kinetics. PG fluxes were
significantly greater (P< 0.05) than the control. The
increase of PG permeation can be mainly ascribed to the
enhancer effect of GMO/mineral oil system and not to the
increase of the drug solubility in the system, since
saturated preparations of PG were used (Table I). In
addition, the pre-treatment experiments showed that
GMO/mineral oil systems might have caused changes on
the hairless mouse SC, which provoked an increase on the
PG flux (about 4.5 times compared to controls). Since the
permeability of lipophilic drugs through human skin has
been found to be slightly higher than in hairless skin
(Morimoto et al., 1991), a greater permeation rate might
be expected in man. The profound hydration effect on skin
or SC under in vitro experimental conditions must also be
considered (Scheuplein et al., 1969). Nevertheless, our
results are still very useful, because tissue is hydrated
easily, and more under occlusion, than in most drug
transdermal administrations (patch) (Guy et al., 1987).
The mechanism of topical delivery involves mainly
the direct transfer of drugs to the lipid phase of the SC
(Golden et al., 1987). The SC lipids are arranged in
multiple bilayers providing alternate hydrophobic and
hydrophilic barriers (Abraham et al., 1995). In general,
routes of skin penetration are classified into two pathways,
polar and non-polar in the intercellular domain. In a study
of the action of enhancers on transdermal delivery, Ogiso
et al. (1995) observed that GMO and oleic acid increased
the flux across skin of a lipophilic drug (indomethacin)
and of a hydrophilic drug (urea), and also the fluidity of
SC lipids.
Fatty acids are the most abundant lipids in biological
membranes, where they exist in free form but also as
components of more complex lipids such as ceramides,
triglycerides and phospholipids. Administration of
exogenous free fatty acids, mainly of the cis-unsaturated
variety, has been reported to increase membrane
permeability (Potts et al., 1991; Tanojo et al., 1997; Gao,
Singh, 1998). GMO has a similar structure to oleic acid,
with a cis-unsaturated double bound in the molecule. It
was initially proposed that the presence of cis double
bounds introduces an accentuated flexion of the
hydrocarbon chain, which prevents the formation of well-
ordered compact crystals (Golden et al., 1986). Results
obtained by attenuated total reflectance infrared
spectroscopy ATIR suggest that the action of oleic acid
could be due to two mechanisms, lipid fluidity and lipid
phase separation (Tanojo et al., 1997). It has been
proposed that lipids like oleic acid and GMO which have
a polar head and a carbon chain presenting a low melting
point increase membrane permeability by promoting
intercellular lipid disorder (Ogiso et al., 1995) and
interactions between a hydroxyl group of GMO and the
anionic oxygen in the polar head of phospholipids
(Maggio, Lucy, 1976).
Morphological methods for visualization of the
structures of SC such as SEM are useful for the
determination of the structural changes caused by different
types of penetration enhancer and the impact of different
types of vehicle on SC membrane structure (Bentley et al.,
1997; Pflucker et al., 1999). In fact, the present SEM
studies showed some changes occurred in the intercellular
space among the corneocytes for all skin samples treated
with GMO formulation (Figure 2).
The corneocytes appear in their characteristic
polygonal shape and seem to be intact, and judging from
the intercellular spaces, to lie very close to each other (Fi-
gure 2a and 2b). Treatment with GMO/ethanol aqueous
solution caused a change in the intercellular regions;
junctions between the cells were loosened, leading to
increased cell separation (Figure 2c and 2d). Considering
the resolution characteristics of SEM technique, it can be
TABLE I - Influence of GMO/mineral oil on in vitro permeation of progesterone across hairless mice stratum corneum*
Formulation Progesterone Flux Flux after
concentration** (µg/cm2.h-1) pre-treatment***
(mg/mL) (µg/cm2.h-1)
20%(w/w) GMO in mineral oil 3.5 4.7 (± 0.1) 6.3 (± 0.32)
Mineral oil (Control) 1.2   1.4 (± 0.07) 1.8 (± 0.08)
* Data refer to means ± SEM of 10 experiments. Non parametric Kruskal-Wallis statistical analysis: P< 0.05 significant;
** Saturated PG solutions; *** Pre-treatment period: 3 h; formulation applied after pre-treatment: saturated PG solutions.
GMO: glycerol monooleate.
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suggested the effect of GMO on the SC junction, which is
mainly formed by lipids. Because of the atoxicity of
GMO, even for food use, and the constant turn over of the
skin in vivo these changes caused by GMO should not be
considered a problem for human use.
CLSM has been used to localize the transport
pathways of the macromolecules and fluorescent labels in
the skin after electroporation, iontophoresis and
application of liposomes and absorption enhancers, to
assess the effect of these methods on increasing (trans)
dermal and transmucosal transport (Marttin et al., 1997;
Van Kuijk-Meuwissen et al., 1998; Kirjawainen et al.,
1999; Lombry et al., 2000). The CLSM images parallel to
the surface of the skin provide information about the
distribution pattern of the fluorescent marker in the SC. In
this way, the penetration profiles of the label into the skin
can be compared after application of different formu-
lations. In order to obtain information about the
penetration of a fluorescent label into deeper layers of the
skin, cross-sections perpendicular to the skin were
required and subsequently collecting of CLSM images
parallel to the plane of these sections.
In the present study fluorescein was used only as a
fluorescent probe and no longer can be related to PG
penetration. The information that CLSM gives is only
about the effect of GMO on the skin, altering its barrier
FIGURE 2 - Scanning electron micrographs of hairless mouse SC: (a) surface of SC control (2,000X); (b) surface of SC
treated with 20% (w/v) GMO in 50% (v/v) ethanol water solution (2,000X); (c) transverse section of SC control
(2,000X); (d) transverse section of SC treated with 20% (w/v) GMO in 50% (v/v) ethanol water solution (4,000X). Bar
indications represent 10 mm. SC: stratum corneum; GMO: glycerol monooleate.
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effect. As shown in Figure 3, the extent of penetration of
fluorescein into the skin after 3 h was visualized by
CLSM. This method resulted in images in which the SC,
viable epidermis and dermis are visualized in the same
focal plane, without a decrease in intensity due to
intervening layers of tissue.
Only a slight fluorescent band was observed on the
surface of the skin after treatment with fluorescein in the
absence of GMO (Figure 3b). When GMO was presented
in the formulation, fluorescence spread deeply reached the
viable epidermis and dermis (Figure 3c). Confocal
microscopy studies showed, therefore, that skin
penetration of fluorescein increased remarkably after
treatment with GMO.
CONCLUSIONS
Lipids have been studied as potential absorption
enhancers for transdermal drug delivery. Considering the
non-toxicity of GMO even for internal use and in vitro
permeation enhancement found in this and other work
(Ogiso et al., 1995), it can be proposed as a promising skin
absorption enhancer. Additionally, our results of SEM and
CLSM in animal model provided understandings about
the effects of GMO on the SC and in vivo fluorescent
probe penetration into the skin, respectively. The present
data, while needing further validation by experiments on
human skin indicate the possibility of using GMO as an
absorption enhancer. Further studies, now in progress, will
FIGURE 3 - Confocal images of mechanical cross-sections (perpendicular series) of hairless mouse skin, optically
sectioned 10 mm below the cutting surface: (a) control (untreated skin); skin treated with: (b) 50% (v/v) ethanol water
solution (control): (c) 20% (w/w) GMO in 50% (v/v) ethanol water solution. Both formulations contained 100 mg
fluorescein/mL. Bar indications represent 100 mm. SC: stratum corneum; GMO: glycerol monooleate.
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be addressed to the evaluation of absorption enhancer
effect of GMO for drugs with a range of lipophilicity as
well as to elucidate the GMO concentration and time of
application influences in this effect by in vitro permeation
and in vivo confocal microscopy studies.
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RESUMO
Sistemas monoleína/solventes para a liberação
transdérmica da progesterona: estudos de
permeação cutânea e microscópicos
A liberação transdérmica de muitos fármacos é
dificultada pelas características de barreira do estrato
córneo. Promotores químicos de absorção cutânea são
capazes de interagir com os constituintes do estrato
córneo, induzindo aumento temporário e reversível na
permeabilidade da pele. O objetivo deste trabalho foi
avaliar a influência de sistemas monoleína (monoleato de
glicerol)/solventes na absorção percutânea de um
fármaco lipofílico (a progesterona), através do estrato
córneo de camundongos sem pelo, bem como o efeito da
monoleína nas características estruturais do estrato
córneo, por meio de microscopia eletrônica de varredura
(SEM) e microscopia de varredura confocal a laser
(CLSM). As alterações morfológicas observadas no estra-
to córneo de camundongos sem pelo sugerem efeito da
monoleína na barreira da pele. E, ainda, o aumento no
fluxo in vitro da progesterona, bem como na penetração
in vivo do marcador fluorescente (fluoresceína), apontam
a monoleína como potencial promotor de absorção
cutânea. Os resultados obtidos mostraram que os sistemas
monoleína/solventes provocaram alterações na estrutura
do estrato córneo, que poderiam causar o aumento da
permeação da progesterona através da pele de camun-
dongos sem pelo, otimizando, deste modo, a liberação
transdérmica deste fármaco.
UNITERMOS: Monoleína. Promotor de absorção cutânea.
Microscopia eletrônica de varredura. Microscopia de var-
redura confocal a laser. Permeação in vitro.
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